Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL19260686

Nc1c2ccccc2nc2cc(OCCCN3CCCC3)cc(C3CCOCC3)c12.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 10/20 0.43
HRH3 Q9Y5N1 10/20 0.43
ADRA1A P35348 7/20 0.43
CACNA1B Q00975 3/20 0.41
HTR4 Q13639 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
AVPR1B P47901 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19260675 0.78 HRH3 (0.50) KCNH2HRH3ADRA1AHTR4KDM4E
Trifluoroacetic Acid SCHEMBL19260825 0.74 HRH3 (0.53) KCNH2HRH3ADRA1ACACNA1BKDM4E
Trifluoroacetic Acid SCHEMBL20720681 0.70 EHMT2 (0.55)
SCHEMBL19260826 0.69 HRH3 (0.51) KCNH2HRH3ADRA1AKDM4EALDH1A1
SCHEMBL20720682 0.68 EHMT2 (0.43) HTR4
Trifluoroacetic Acid SCHEMBL19260754 0.67 EHMT2 (0.49)
SCHEMBL19260636 0.66 HRH3 (0.56) KCNH2HRH3ADRA1AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL20720766 0.65 EHMT2 (0.54)
Formic Acid SCHEMBL19260676 0.64 KDM4E (0.46) KCNH2HRH3ADRA1AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL19260764 0.64 EGFR (0.51) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3416963-A1 HISTONE METHYLTRANSFERASE INHIBITORS Global Blood Therapeutics, Inc. (US) 2018-12-26 EP disclosed
WO-2017142947-A1 HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2017-08-24 WO disclosed